Prevalence estimation of selected fungal infections for today and a forecast for the year 2000, covering key countries
Abstract:
Estimations of the potential market volume for new products should be developed from clinical and epidemiological data (number of patients) as a basis, rather applying straightforward estimations of sales volumes. The goals of the study presented here were twofold: Estimate the number of patients suffering from specific fungal infections Develop an operating procedure to estimate the incidence and prevalence figures for systemic mycosis for published clinical and epidemiological data. The technical difficulty was to put the pieces of information together in an appropriate manner, in order to obtain reliable and reproducible data. As a part of the project some operating procedures for the retrieval, selection and documentation (single item references) were established. To ensure the best possible quality of data, the estimation and forecasting of mean lower and upper bound for data values was required. Some basic guidelines for data selection and data modelling were developed. The database software was chosen with respect to easy handling, updating and viewing of data.
Case Studies
A case study on client-agency teamwork in the market research process
Catalogue: EphMRA/ESOMAR Conference 1997: Sharpening Tools For The Future
Authors: Richard Beswick, Urs Mattes
Company: bms Ltd.
June 15, 1997
Research Papers
A healthy dose of normality
Catalogue: Global Healthcare 2010: Trends And Innovation Booster
Author: Andrew Vincent
 
March 3, 2010
Research Papers
Standardization of health measurement for different indications
Catalogue: EphMRA/ESOMAR Seminar 1991: 1993 And Beyond
Author: Peter Becker
 
June 15, 1991
